Activase 100 MG vials
Ended Awarded
- Contract number
- SPE2DR26FCFGC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,465
Award facts
- Contract value 100% obligated
- $11,465.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $11,465 delivery order to Amerisourcebergen Drug Corp on June 11, 2026, for 100 mg vials of Activase (alteplase), a thrombolytic agent used in acute myocardial infarction and stroke treatment across military healthcare systems.
The order was issued under a single-award indefinite delivery contract with the Defense Logistics Agency Troop Support Medical and carries a firm fixed-price structure. Place of performance is Conshohocken, PA. The ultimate completion date is June 12, 2026.
Quick answers
Who was awarded contract SPE2DR26FCFGC?
SPE2DR26FCFGC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 11, 2026.
How much is contract SPE2DR26FCFGC worth?
The government has obligated $11,465 on SPE2DR26FCFGC.
Is contract SPE2DR26FCFGC an order under another contract?
Yes. SPE2DR26FCFGC is a delivery order under SPE2DR25D1120, an indefinite delivery contract.
Was contract SPE2DR26FCFGC competed?
The extent of competition for SPE2DR26FCFGC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award